Loading clinical trials...
Loading clinical trials...
Cohort study enrolled high-risk Hodgkin Lymphoma patients in first relapse after induction therapy followed after remission either with a systemic imaging-based surveillance (Imaging cohort) or with s...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Federico II University
NCT07471841 · IDH1 Mutation, Relapsed / Refractory AML
NCT06347068 · Breast Cancer, Relapse, and more
NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more
NCT07425782 · Acute Myeloid Leukemia, Consolidation Therapy, and more
NCT05169515 · Non-Hodgkin Lymphoma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions